Daiichi Sankyo denies receiving takeover bid from AstraZeneca

LONDON (Reuters) - Japan's Daiichi Sankyo denied on Thursday it had received a takeover bid last year from British drugmaker AstraZeneca, as reported earlier by the online version of Nikkei Business. "This is not the fact," the company said in a short statement. AstraZeneca had earlier declined to comment on the report, which sent the Japanese group's share price soaring as much as 13 percent and triggered a trade suspension. (Reporting by Ben Hirschler; Editing Martinne Geller)